{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:55:56Z","timestamp":1785855356684,"version":"3.56.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1097\/01.inf.0000164707.13624.a7","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T04:02:27Z","timestamp":1117598547000},"page":"494-497","source":"Crossref","is-referenced-by-count":29,"title":["Antimicrobial-Resistant Shigella sonnei"],"prefix":"10.1097","volume":"24","author":[{"given":"Sanjay K.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Siberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1086\/386326","article-title":"Laboratory-confirmed shigellosis in the United States, 1989\u20132002: epidemiologic trends and patterns.","volume":"38","author":"Gupta","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/infdis\/168.5.1177","article-title":"Evaluation of an intervention program for the control of an outbreak of shigellosis among institutionalized persons.","volume":"168","author":"Mahoney","year":"1993","journal-title":"J Infect Dis"},{"key":"R4-4-20210202","first-page":"2363","article-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. vol 2.","author":"DuPont","year":"2000"},{"key":"R5-4-20210202","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/infdis\/162.5.1107","article-title":"Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers.","volume":"162","author":"Tauxe","year":"1990","journal-title":"J Infect Dis"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/313715","article-title":"Emergence of antimicrobial-resistant shigellosis in Oregon.","volume":"30","author":"Replogle","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R8-4-20210202","first-page":"552","article-title":"Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed.","year":"2003"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","article-title":"Practice guidelines for the management of infectious diarrhea.","volume":"32","author":"Guerrant","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-126-9-199705010-00004","article-title":"Treatment of shigellosis, V: comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial.","volume":"126","author":"Khan","year":"1997","journal-title":"Ann Intern Med"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.inf.0000060829.48485.2e","article-title":"Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children.","volume":"22","author":"Basualdo","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R12-4-20210202","first-page":"654","article-title":"Manual of Clinical Microbiology. 8th ed.","author":"Bopp","year":"2003"},{"key":"R13-4-20210202","first-page":"19087","article-title":"Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement.","year":"2004"},{"key":"R14-4-20210202","first-page":"19087","article-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 6th ed.","year":"2004"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0732-8893(98)00146-1","article-title":"Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains.","volume":"33","author":"Stock","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1542\/peds.103.2.e18","article-title":"Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome.","volume":"103","author":"Khan","year":"1999","journal-title":"Pediatrics"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/003655400750045358","article-title":"Shigellosis of childhood in northern Greece: epidemiological, clinical, and laboratory data of hospitalized patients during the period 1971\u20131996.","volume":"32","author":"Kavaliotis","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3476(05)83392-X","article-title":"Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children.","volume":"118","author":"Varsano","year":"1991","journal-title":"J Pediatr"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-200011000-00006","article-title":"Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.","volume":"19","author":"Leibovitz","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0022-3476(05)80868-6","article-title":"Comparative efficacy of two- and five-day courses of ceftriaxone for treatment of severe shigellosis in children.","volume":"123","author":"Eidlitz-Marcus","year":"1993","journal-title":"J Pediatr"},{"issue":"suppl","key":"R22-4-20210202","first-page":"7","article-title":"Oral kanamycin in the treatment of Shigella and Salmonella infections.","author":"Parry","year":"1967","journal-title":"Postgrad Med J"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/tropej\/40.6.320","article-title":"Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.","volume":"40","author":"Islam","year":"1994","journal-title":"J Trop Pediatr"},{"key":"R24-4-20210202","first-page":"496","article-title":"Cephradine in the treatment of intestinal infections caused by Shigella or Salmonella organisms.","volume":"14","author":"Landa","year":"1972","journal-title":"Curr Ther Res Clin Exp"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000441-198107000-00004","article-title":"Antibiotic treatment of acute shigellosis: failure of cefamandole compared with trimethoprim\/sulfamethoxazole and ampicillin.","volume":"282","author":"Orenstein","year":"1981","journal-title":"Am J Med Sci"},{"issue":"suppl 4","key":"R26-4-20210202","first-page":"82","article-title":"Comparison of cefaclor and ampicillin in the treatment of shigellosis.","volume":"55","author":"Ostrower","year":"1979","journal-title":"Postgrad Med J"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3476(05)80867-4","article-title":"Randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis.","volume":"123","author":"Ashkenazi","year":"1993","journal-title":"J Pediatr"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00006454-200006000-00006","article-title":"Treatment of shigellosis with cefixime: two days vs. five days.","volume":"19","author":"Martin","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R29-4-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-123-7-199510010-00005","article-title":"Therapy for shigellosis, IV: cefixime is ineffective in shigellosis in adults.","volume":"123","author":"Salam","year":"1995","journal-title":"Ann Intern Med"},{"key":"R30-4-20210202","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3476(88)80029-5","article-title":"Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.","volume":"113","author":"Salam","year":"1988","journal-title":"J Pediatr"},{"key":"R31-4-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00006454-200404000-00022","article-title":"Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis.","volume":"23","author":"Miron","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R32-4-20210202","first-page":"91","article-title":"Tissue-directed pharmacokinetics.","volume":"12","author":"Schentag","year":"1991","journal-title":"Am J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.inf.0000164707.13624.a7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:36:10Z","timestamp":1785854170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200506000-00004"}},"subtitle":["Limited Antimicrobial Treatment Options for Children and Challenges of Interpreting In Vitro Azithromycin Susceptibility"],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000164707.13624.a7","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}